1 March 2022 - PHARMAC has confirmed that the purchase price of the annual influenza vaccine will increase by $2 a dose, the first increase since 2008.
“The influenza vaccine has been supplied at $9 a dose for the last 14 years,” says Pharmac’s Director of Operations Lisa Williams. “The supplier, Seqirus, has advised us that they are increasing the price of the vaccine in New Zealand, from $9 a dose to $11.”
The confidential net price to PHARMAC is unchanged, so to the price change doesn’t impact the Combined Pharmaceutical Budget.